Advisors Asset Management Inc. Has $7.65 Million Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Advisors Asset Management Inc. raised its stake in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 24.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 73,070 shares of the company's stock after buying an additional 14,496 shares during the quarter. Advisors Asset Management Inc.'s holdings in Church & Dwight were worth $7,651,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of CHD. YANKCOM Partnership acquired a new position in Church & Dwight during the 4th quarter valued at about $25,000. Versant Capital Management Inc raised its holdings in shares of Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company's stock valued at $28,000 after buying an additional 184 shares during the last quarter. Strategic Financial Concepts LLC acquired a new position in shares of Church & Dwight during the fourth quarter worth approximately $39,000. Bank of Jackson Hole Trust bought a new position in Church & Dwight in the 4th quarter worth approximately $43,000. Finally, Golden State Wealth Management LLC acquired a new stake in Church & Dwight in the 4th quarter valued at approximately $51,000. Institutional investors and hedge funds own 86.60% of the company's stock.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the completion of the transaction, the executive vice president now owns 10,497 shares of the company's stock, valued at $1,217,442.06. This represents a 83.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Rene Hemsey sold 11,060 shares of the firm's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the completion of the transaction, the executive vice president now owns 6,437 shares of the company's stock, valued at $707,941.26. The trade was a 63.21 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 65,570 shares of company stock worth $7,538,449. Insiders own 2.00% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Barclays increased their price target on Church & Dwight from $90.00 to $93.00 and gave the stock an "underweight" rating in a research note on Tuesday, February 4th. Piper Sandler decreased their target price on shares of Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. dropped their price target on shares of Church & Dwight from $107.00 to $106.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. Royal Bank of Canada reiterated a "sector perform" rating and issued a $105.00 price objective on shares of Church & Dwight in a report on Monday, February 3rd. Finally, Stifel Nicolaus boosted their target price on Church & Dwight from $103.00 to $105.00 and gave the stock a "hold" rating in a report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $111.56.

Church & Dwight Stock Performance

Church & Dwight stock traded down $1.03 during trading hours on Friday, hitting $107.04. The stock had a trading volume of 2,520,943 shares, compared to its average volume of 1,392,263. Church & Dwight Co., Inc. has a fifty-two week low of $96.35 and a fifty-two week high of $116.46. The company has a market cap of $26.33 billion, a PE ratio of 45.16, a price-to-earnings-growth ratio of 3.32 and a beta of 0.57. The company has a 50-day moving average of $107.42 and a two-hundred day moving average of $105.88. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the business posted $0.65 earnings per share. On average, equities research analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were given a dividend of $0.295 per share. This is a boost from Church & Dwight's previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.18 annualized dividend and a dividend yield of 1.10%. Church & Dwight's payout ratio is currently 49.79%.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.